ROCKVILLE, Md.--(BUSINESS WIRE)-- Human Genome Sciences, Inc. (NASDAQ:HGSI) announced today that its presentation at the Goldman Sachs 31st Annual Global Healthcare Conference will be webcast and may be accessed at www.hgsi.com.
A member of Human Genome Sciences’ senior management team will present a corporate overview on Tuesday, June 15, 2010, at 11:00 AM Eastern. Investors interested in listening to the live webcast should log on before the start time in order to download any software required. The archive of the webcast will be available for several days after the live event.
The mission of HGS is to apply great science and great medicine to bring innovative drugs to patients with unmet medical needs. The HGS clinical development pipeline includes novel drugs to treat hepatitis C, lupus, inhalation anthrax and cancer.
HGS and Human Genome Sciences are trademarks of Human Genome Sciences, Inc. For additional information on Human Genome Sciences, Inc., visit the company’s web site at www.hgsi.com.
CONTACT:
Human Genome Sciences, Inc.
Media Contact:
Jerry Parrott
Vice President, Corporate Communications
301-315-2777
or
Investor Contact:
Peter Vozzo
Senior Director, Investor Relations
301-251-6003
KEYWORDS: United States North America Maryland
INDUSTRY KEYWORDS: Health Biotechnology Clinical Trials Genetics Pharmaceutical
MEDIA:
| Logo |